Stealth BioTherapeutics OverviewStealth BioTherapeutics Net Income
Profitability analysis for MITO.
Quarterly Net Income
-$2.66M
↑ 65.44% YoY
As of Mar 2022
Annual Net Income (TTM)
-$54.29M
↓ 9.44% YoY
Trailing 12 months ending Mar 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...